Cryo-Cell International (FRA:ZCY) Total Equity: €-15.57 Mil (As of Feb. 2026)


FRA:ZCY Cryo-Cell International Inc FRA:ZCY
63 GF Score
Price €2.86
GF Value €4.50
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International Total Equity?

Cryo-Cell International FRA:ZCY +2.88% 63 Total Equity is €-15.57 Mil as of Feb. 2026. GuruFocus rates FRA:ZCY with a GF Score™ of 63/100 and a GF Value™ of €4.50 (Possible Value Trap). The stock has 4 warning signs investors should review.

Cryo-Cell International's total equity for the quarter that ended in Feb. 2026 was €-15.57 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Cryo-Cell International Total Equity Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Total Equity Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.67 -1.50 -10.19 -12.45 -16.09

Cryo-Cell International Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.07 -13.80 -12.74 -16.09 -15.57
FRA:ZCY
63GF Score
Cryo-Cell International Inc FRA:ZCY
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Cryo-Cell International's Total Equity for the fiscal year that ended in Nov. 2025 is calculated as

Total Equity=Total Assets(Q: Nov. 2025 )-Total Liabilities(Q: Nov. 2025 )
=53.396-69.489
=-16.09

Cryo-Cell International's Total Equity for the quarter that ended in Feb. 2026 is calculated as

Total Equity=Total Assets(Q: Feb. 2026 )-Total Liabilities(Q: Feb. 2026 )
=51.509-67.075
=-15.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €-15.57 Mil mean?
Cryo-Cell International (FRA:ZCY) has a Total Equity of €-15.57 Mil as of Feb. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Cryo-Cell International and its competitors.
Is Cryo-Cell International's Total Equity too high?
Cryo-Cell International's current Total Equity is €-15.57 Mil. Overall, Cryo-Cell International has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Total Equity compare to CCM and CDIX?
Cryo-Cell International's Total Equity of €-15.57 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Cryo-Cell International and its competitors. Cryo-Cell International's current Total Equity is €-15.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (FRA:ZCY) is currently considered Possible Value Trap. The stock's GF Value™ is €4.50, compared to a current price of €2.86 — trading 36.4% below its estimated fair value. The current Total Equity is €-15.57 Mil. Cryo-Cell International's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Cryo-Cell International (FRA:ZCY), the current Total Equity is €-15.57 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (FRA:ZCY) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of €2.86 is trading 36.4% below its estimated GF Value™ of €4.50. GuruFocus considers Cryo-Cell International to be Possible Value Trap.

Key valuation signals for FRA:ZCY:

  • Total Equity: €-15.57 Mil
  • GF Value™: €4.50 vs. price of €2.86 (36.4% below fair value)
  • GF Score™: 63/100 with 4 warning signs

No single metric tells the full story. See the FRA:ZCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cryo-Cell International Business Description

Other Exchanges CCEL:USA
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
63GF Score

Get the complete analysis for FRA:ZCY

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.86
Price
€4.50
GF Value